Teng-Yu Lee

23PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersHaematologyDisease surveillanceMedical biochemistry - proteins and peptides (incl. medical proteomics)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Mar 27, 2026
Letter: Beyond Association-Operationalising PRS-5 for Hepatocellular Carcinoma Surveillance. Authors' Reply.

Yu-Sheng Lin, Ying-Cheng Lin, Teng-Yu Lee

|Mar 18, 2026
Editorial: Residual HCC Risk After Hepatitis C Cure-Can Polygenic Risk Scores Refine Surveillance? Authors' Reply.

Yu-Sheng Lin, Hwai-I Yang, Teng-Yu Lee

|Mar 07, 2026
Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR. Authors' Reply.

Yu-Sheng Lin, Yun-Yu Chen, Teng-Yu Lee

|Feb 11, 2026
Validated Nationwide Scoring System for Hepatocellular Carcinoma Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Teng-Yu Lee, Sherlot Juan Song, Hsiu J Ho

|Feb 08, 2026
Liver Steatosis-Related Polygenic Risk Score Predicts Hepatocellular Carcinoma Risk After Hepatitis C Virus Eradication.

Yu-Sheng Lin, Ying-Cheng Lin, Yun-Yu Chen

|Jan 28, 2026
Serum Outperforms Plasma for Glypican-3 Quantification in Hepatocellular Carcinoma-A Prospective Comparative Study.

Ming-Tze Yang, Jiunn-Min Wang, Chen-Shiou Wu

Pageof 4